Epidermal growth factor and transforming growth factor-alpha decrease gamma interferon receptors and induction of intercellular adhesion molecule (ICAM-1) on cultured keratinocytes by Mitra, Raj S. & Nickoloff, Brian J.
JOURNAL OF CELLULAR PHYSIOLOGY 150:264268 (1992) 
Epidermal Growth Factor and Transforming 
Growth Factor-Alpha Decrease Gamma 
Interferon Receptors and Induction of 
lntercellular Adhesion Molecule (ICAM-1 ) on 
Cu Itu red Keratinocytes 
RAJ S. MITRA AND BRIAN J.  NICKOLOFF* 
Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 
48 109-0602 
The link between the epidermal keratinocytes of the skin and the activated T 
lymphocytes of the immune system is mediated by a variety of cytokines, includ- 
ing gamma interferon (IFN-y). We studied the influence of keratinocyte mitogens 
such as transforming growth factor-alpha (TGF-a), epidermal growth factor (EGF), 
and somatomedin-C (SM-C) on the ligand binding of '2P-labelled IFN-y to cul- 
tured keratinocytes derived from normal appearing adult. human skin. Kerati- 
nocytes placed in a medium devoid of mitogens become growth arrested, and 
these quiescent cells expressed 2.4 times (28,900 versus 12,200 sitesicell) as 
many high affinity IFN-y receptors (Kd = 0.22 nM) compared to keratinocytes 
which were actively growing in medium containing TGF-a (25 ng/mI) or EGF (10 
ngiml). The reduction in IFN-y receptor sites by TGF-aiEGF was mitogen specific, 
as adding SM-C (500 ng/ml) did not have any effect on ligand binding, although it 
similarily stimulated keratinocyte growth. The reduction in IFN-y receptors was 
time dependent, occurring primarily after 24-48 hours of change in tissue culture 
conditions. The reduction in the number of high affinity IFN-y receptors by TGF- 
a/EGF had immunobiological consequences, because quiescent keratinocytes in 
basal medium had an increased expression of HLA-DR and intercellular adhesion 
molecule-1 (ICAM-1) induced by IFN-y, compared to actively growing TGF-a/ 
EGF treated keratinocytes. These results suggest that rapidly proliferating kerati- 
nocytes exposed to TGF-a/EGF but not SM-C are capable of altering their response 
to IFN-y by decreasing their number of cell surface high affinity receptors for 
IFN-?/ 
The interferons are a large family of glycoproteins 
which were initially identified because of their antivi- 
ral activity, but also have been found to be capable of 
modulating cellular proliferation and immunological 
reactions (reviewed in Lengyel, 1982). Within the last 
few years, the biochemistry and physiology of interfer- 
ons has become of increasing interest among investiga- 
tive dermatologists (Nickoloff, 1991b). The human re- 
ceptor for gamma interferon (IFN-y) has been cloned 
and expressed by several groups, which have discov- 
ered that there must exist an additional species-specific 
component, besides the receptor itself, necessary for 
functional activity (Aguet et al., 1988; Gray et al., 
1989). Despite these elegant molecular biological inves- 
tigations, relatively little is known regarding the mod- 
ulation of IFN-y receptor expression on the cell surface 
of keratinocytes, or other cell types (Nickoloff, 1987). 
Our laboratory for the past several years has been in- 
terested in elucidating the potentially important role of 
IFN-y, and its receptor, on keratinocytes with particu- 
lar emphasis on psoriasis (reviewed in Nickoloff, 1988). 
We have recently proposed that one abnormality in the 
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cytokine network by which the hyperkinetic psoriatic 
keratinocytes may arise is via functional inactivation 
of the growth inhibitory pathway mediated by high 
affinity IFN-y receptors on lesional keratinocytes 
(Nickoloff, 199 1 a). 
Using normal cultured human keratinocytes, IFN-y 
has been documented to reduce the number of high 
affinity EGF receptor sites by approximately 50% 
(Nickoloff and Mitra, 1989). In this study, we posed the 
reciprocal question: could epidermal growth factor 
(EGF) and/or TGF-a influence IFN-y cell surface recep- 
tors on cultured keratinocytes? 
MATERIALS AND METHODS 
Keratinocyte culture 
Primary keratinocyte cultures were obtained after 
informed consent from normal appearing skin of 
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healthy adult volunteers without any skin disease, and 
ingesting no medication, using a Castroviejo keratome, 
and preparing a single cell suspension as previously 
described (Nickoloff et al., 1989). The freshly isolated 
epidermal cells were seeded into 35 mm plastic petri 
dishes (Lux, Flow Laboratories, Naperville, IL) and 
grown in the presence of a low calcium (0.15 mM), se- 
rum free medium containing EGF (10 ng/ml), insulin (5 
pg/ml), hydrocortisone (0.5 pgiml), bovine pituitary ex- 
tract 0.4% v/v, designated KGM (Clonetics Corp, San 
Diego, CAI. Keratinocytes were passaged routinely 
with 0.03% trypsin/O.Ol% EDTA, and used between 
passage number 2 and 4. 
Growth modulatory treatments 
Rapidly growing undifferentiated keratinocytes 
maintained in KGM can be growth arrested at  low cell 
densities by replacing the KGM with a basal medium 
devoid of the mitogens EGF, insulin, and pituitary ex- 
tract (designated KBM; Clonetics Corp). Based on our 
previous work (Nickoloff, 1988), these quiescent cul- 
tures can be reactivated to proliferate by supplement- 
ing the KBM with either EGF (10 ng/ml; receptor 
grade, Collaborative Research, Inc., Bedford, MA), 
TGF-a (25 ng/ml; Collaborative Research, Inc.), or re- 
combinant somatomedin-C (SM-C) which is also re- 
ferred to as insulin-like growth factor-1 (500 ngiml; 
Collaborative Research, Inc.). In a standard binding 
assay, keratinocytes a t  different seeding density 
(range = 4-6 x lo4  cells) were placed in 24-well plates 
and grown in KGM to sub-confluency. Keratinocytes 
were washed 3 times with 1 ml KBM, and then placed 
in KBM for 18-24 hours. After this incubation with 
KBM, the keratinocytes were then exposed for the next 
48 hours to either KBM alone, KGM, KBM + EGF (10 
ng/ml), KBM + TGF-a (25 ngiml), KBM + SM-C (500 
ng/ml), or KBM + EGF (10 ng/ml) + SM-C (500 ngiml). 
Radiolabelling of IFN-y 
Radiolabelling of IFN-y was accomplished using 
Y - ~ ~ P - A T P  and the procedure described by Mariano 
et al. (1987) and Langer et al. (1986). Briefly, 1 pg of 
recombinant human IFN-y (A.C. Feldman, Genentech, 
Inc., South San Francisco, CA) having a specific activ- 
ity of 2.5 x lo7 units/mg was incubated for 60 minutes 
a t  30°C with 250 pCi of y3,P-ATP (Amersham Corp, 
Arlington Heights, IL; > 5,000 Ci/mmol), and 5 units of 
the catalytic subunit of CAMP-dependent protein ki- 
nase from bovine heart muscle (Sigma Chemical CO., 
St. Louis, MO; P-2645) in 30 pl of 20 mM Tris-HC1 (pH 
7.4), 1 mM dithiothreitol, 100 mM NaC1, and 12 mM 
MgC1,. The reaction was terminated by cooling on ice 
and adding 600 pl of 5 mg/ml bovine serum albumin 
(Sigma Chemical Co.) in 10 mM sodium pyrophosphate 
(pH 6.7). Then 10 mM sodium p rophosphate, pH 6.7 (3 
liters), was used to dialyze the 'P-labelled IFN-y (32P- 
IFN-y) overnight a t  4°C (dialysis tubing 12,000 molecu- 
lar weight cutoff; Bethesda Research Labs, MD; 
#5961). After dialysis, the 32P-IFN-y was aliquoted 
into 100 pl fractions and stored a t  -80°C, and used 
within 2 weeks of labelling. The specific activity of the 
32P-IFN-y after dialysis resulted in a representative 
yield of 980 Cilmmol. The biological activity of the 32P- 
IFN-y was verified by comparing the ability of 1 Uiml, 
5 Uiml, 10 Uiml, and 50 Uiml of 32P-IFN-y versus non- 
labelled IFN-y to induce HLA-DR and ICAM-1 on cul- 
tured keratinocytes grown in 8-well Lab-Tek chambers. 
After 48 hr, the cells were fixed in acetone and immu- 
nostained for HLA-DR (Becton-Dickenson, Mountain 
View, CA) and ICAM-1 (RR1/1; Dr. T. Springer, Boston, 
MA) using a sensitive avidin-biotin detection system 
(Vectastain Kit, Vector-Labs, Burlingame, CA). After 
dialysis, 32P-IFN-y was also run on a 15% SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) with and 
without addition of 2-mercaptoethanol (5%) as previ- 
ously described with appropriate molecular weight 
standards (Rashidbaigi et al., 1985). Following electro- 
phoresis, the gel was dried and autoradiographed 
(Kodak X-Omat film). 
Ligand binding assay 
After the 48 hr  growth and differentiation modula- 
tory treatment, keratinocytes were washed 3 times 
over a 3 hr  time interval in ligand binding buffer 
(Earle's balanced salt solution (EBSS), containing 0.2% 
bovine serum albumin, RIA grade, Sigma Chemical 
Co.). The cells were chilled on ice and incubated with 
0.4 ml of binding buffer and varied concentrations of 
32P-IFN-y and non-labelled IFN-y. The cultures were 
maintained a t  4°C for the duration of the binding assay 
(4 hr), which was terminated by washing the monolay- 
ers 3 times with 1.5 ml ice-cold binding buffer. Solubili- 
zation of the cells was accomplished using 1 ml of 0.1 N 
sodium hydroxide plus 1% sodium dodecyl sulfate 
(SDS), followed by liquid scintillation counting. Non- 
specific binding was determined by adding a thousand- 
fold excess of unlabelled IFN-y to parallel sample wells, 
and was no greater than 25% of the total amount bound 
under any treatment conditions. Data points represent 
the average of triplicate samples with non-specific 
binding subtracted. Each figure represents the mean of 
three separate experiments. For each experimental 
condition, the number of keratinocytes per well was 
determined and kept to within 10% of the other wells by 
adjusting the seeding density, since keratinocytes 
maintained for 48 h r  in KBM alone will not signifi- 
cantly increase in cell number, compared to those main- 
tained in KGM or KBM plus EGF/TGF-a and/or SM-C. 
Maintaining the same relative cell density is critical, 
because the expression of cell surface receptors is influ- 
enced by the degree of confluency (Rizzino et al., 1988). 
The two-tailed Student's t-test was performed for sta- 
tistical analysis of differences in receptor sites/cell. 
Immunobiological consequences of reduced 
IFN-7 binding 
To determine the possible immunobiological conse- 
quences of the growth modulatory treatments, kerati- 
nocytes maintained in either KGM, KBM, 
KBM + EGF, KBM + SM-C, or KBM + EGF +SM-C 
for 48 h r  were exposed to IFN-y (1 U/ml, 10 Uiml) for an 
additional 24 hr. These cells were then analyzed for cell 
surface expression of ICAM-1 and HLA-DR by prepar- 
ing single cell suspensions (using 0.03% trypsin, 0.01% 
EDTA) and indirect immunofluorescence staining fol- 
lowed by FACS analysis as previously described 
(Nickoloff et al., 1989). Isotype control (Leu 2a, IgGl; 
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Fig. 1. 
tinocytes maintained in KGM. 
Kinetics of specific "P-IFN-y ligand binding to cultured kera- 
Becton-Dickenson, Mountain View, CA) was sub- 
tracted from the ICAM-1 and HLA-DR results. 
RESULTS 
Characterization of 32P-IFN-y 
To establish that the procedure used to radiolabel the 
IFN-y did not alter the IFN-y, 2 studies were per- 
formed. First, the radiolabelled material was subjected 
to SDS-PAGE under reducing conditions which re- 
vealed that 32P-IFN-y migrates previously as a single 
band with an apparent molecular weight of approxi- 
mately 17,000 daltons with a faint second band at 
34,000 daltons (data not shown), in good agreement 
with previous investigators who have utilized the same 
labelling procedure (Rashidbaigi e t  al., 1985; Sarkar 
and Gupta, 1984). Secondly, the biological activity re- 
tained after phosphorylation was determined by adding 
equivalent concentrations of labelled and unlabelled 
IFN-y (1, 5, 10, 50 Uiml) to keratinocytes grown in 
Lab-Tek chambers, and after 48 hr, examining the im- 
munoperoxidase stained monolayers for ICAM-1 and 
HLA-DR expression by light microscopy. Both IFN-y 
preparations produced equivalent results in the extent 
and intensity of keratinocyte ICAM-l/HLA-DR induc- 
tion with a concentration dependent increase in the 
number of cells positively stained and in the intensity 
of staining (data not shown). 
Time course of 32P-IFN-y binding 
32P-IFN-y bound at 4°C specifically to keratinocytes 
grown in KGM with the binding reaching a plateau 
between 4 and 6 hr (Fig. 11, in good agreement with our 
previous studies using IFN-y which had been labelled 
with lZ5I using the Bolton-Hunter reagent (Nickoloff, 
1987). Non-specific binding was determined by adding 
excess (thousandfold) non-radiolabelled IFN-y, and was 
found to average between 15% and 25% of total binding 
at  4°C. 
Scatchard analysis of binding 
The specific binding of 32P-IFN-y to keratinocytes in 
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Fig. 2. 
maintained in either KBM (solid circles) or KGM (open circles). 
Scatchard plot of 32PP-IFN-y ligand binding to keratinocytes 
of 32P-IFN-y and achieved saturation under both condi- 
tions between 200 and 400 pM (data now shown). Scat- 
chard analysis of the ligand binding data yielded linear 
plots (regression coefficient = 0.9) indicating the pres- 
ence of a single class of high affinity binding sites (Fig. 
2). The dissociation constant for keratinocytes grown in 
KGM was calculated to be 0.25 * .08 nM with 
19,830 & 880 receptor sitedkeratinocyte. 
The Scatchard plots of ligand binding for kerati- 
nocytes switched from KGM to other culture conditions 
revealed significant changes in the number of high af- 
finity IFN-y receptors, without significant alteration of 
the dissociation constants. Keratinocytes placed in 
KBM increased the number of sitesicell to  
28,900 t 1,136 (P < .01 compared to KGM) with a 
Kd = 0.22 i .04 nM. Conversely, adding EGF (10 ngi 
ml) to the KBM reduced the number of sitesicell to 
12,200 i 820, and adding TGF-a (25 ng/ml) to KBM 
also reduced the number of high affinity sitesicell to  
13,800 * 1,261 (P < .01 for both results compared to 
KGM). This reduction was mitogen specific because 
adding SM-C (500 ng/ml1 to KBM, which induces the 
approximately equivalent stimulation of keratinocyte 
growth as EGF (Turbitt et al., 19901, had no effect of 
lowering binding sites (25,800 i 984). When EGF was 
combined with SM-C, the number of binding sites per 
cell was also reduced to 15,300 i 964. 
Kinetics of increased/decreased 32P-IFN-y 
binding by growth modulatory treatment 
Because of our previous experience in which 1251- 
EGF binding to cultured keratinocytes was inhibited 
by IFN-y after 24 and 48 hr  exposure (Nickoloff and 
Mitra, 19891, we performed a similar kinetic analysis 
measuring 32P-IFN-y binding. Figure 3 reveals that 
during the first 15 hr  of incubation in either KGM, 
KBM, or KBM plus EGF there is no significant alter- 
ation in 32P-IFN-y binding. However, between 24 and 
48 hr  of incubation, the KBM had increased 32P-IFN-y 
binding compared to KGM, whereas the KBM plus EGF 
had decreased 32P-IFN-y binding. Thus, the kinetics of 
alteration in 32P-IFN-y binding are similar to changes 
in Iz5I-EGF ligand binding. I t  should be emphasized 
267 EGFITGF-CY DECREASES KERATINOCYTE IFN-y BINDING 
3 -  
2 -  
a 
0 10  2 0  30 4 0  5 0  n hl 
c? 
Time of Treatment (hours) 
Fig. 3. Kinetics of change in "P-IFN-y ligand binding for kerati- 
nocytes maintained in either KBM (solid circles), KGM (triangles), or 
KBM plus EGF (open squares). 
TABLE 1. Induction of ICAM-1 and HLA-DR by IFN-y after 24 hrs* 
IFN-y = 1 U/ml 
Culture conditions ICAM-1 HLA-DR ICAM-1 HLA-DR 
KBM 3 9 f 6  2 8 f 5  1 1 2 f 1 7  5 6 f 8  
KGM 1 8 f 4  12f4 6 8 f 1 1  4 0 f 6  
KBM + EGF 2 1 f 4  14i5 5 7 f 1 0  4 1 1 7  
KBM + SM-C 3 8 + 6  3 0 1 5  113f 14 5 9 f 9  
IFN-y = 10 U/ml 
KBM+EGF+SM-C 1 5 f 5  1 1 f 5  6 7 f 1 0  4 3 f 7  
*FACS analysis of keratinocyte cell surface expression of ICAM-1 and HLA-DR 
induced by IFN-7 under different growth conditions. Background, non-specific 
staining has been subtracted. Values represent mean channel flourescencereadings 
(N = 4). EGF = 10 ng/ml; SM-C = 500 ng/ml. 
that the seeding densities were adjusted appropriately, 
so that similar cell numbers per well (within 10%) were 
present a t  each time point studied for each different 
culture condition. 
Immunobiological effects of growth 
modulatory treatments 
To determine if the alterations in 32P-IFN-y binding 
had any immunobiological consequences, keratinocytes 
which had been previously maintained with the vari- 
ous growth modulatory treatments for 48 hr, were then 
exposed to IFN-y (1 U/ml and 10 Uiml) for an additional 
24 hr  followed by FACS analysis for ICAM-1 and HLA- 
DR. As previously observed for keratinocytes main- 
tained in KGM, a 24 h r  exposure to IFN-y results in 
greater ICAM-1 expression compared to HLA-DR (Grif- 
fiths et al., 198913). Furthermore, keratinocytes main- 
tained under conditions which were associated with re- 
duced 32P-IFN-y ligand binding (i.e., KGM, KBM plus 
EGF, or KBM plus TGF-a) had decreased levels of 
ICAM-1 and HLA-DR induction, compared to kerati- 
nocytes with greater 32P-IFN-y binding (i.e., KBM) 
that had higher ICAM-1/HLA-DR expression (Table 1). 
DISCUSSION 
Interferons exert their pleiotropic biological effects 
by first binding to specific cell surface receptors 
(Langer and Pestka, 1988). Using 17,000 dalton, biolog- 
ically active 32P-labelled IFN-y, a single class of high 
affinity IFN-y receptors was demonstrated by Scatch- 
ard analysis to be present on multi-passaged human 
keratinocytes. The ligand binding studies performed at  
4°C revealed a specific, time dependent (plateau at 4-6 
hours), and saturatable reaction, with the resultant Kd 
and receptorsicell (0.25 nM; 19.8 x lo3, respectively) to 
be within the range of values previously reported char- 
acterizing IFN-y receptors on cells such as kerati- 
nocytes, fibroblasts, WISH cells, and monocytei 
macrophages (Nickoloff, 1987; Mariano et al., 1987; 
Anderson et al., 1982; Finbloom et al., 1985; Sarkar and 
Gupta, 1984; Celada et al., 1984; Orchansky et al., 
1986). Moreover, the current results indicate that the 
number of high affinity IFN-y receptor sitesicell, as 
detected by ligand binding studies, was dependent on 
the growth characteristics of the cultured kerati- 
nocytes. Even though the relative density of the kerati- 
nocytes was maintained relatively constant throughout 
the studies, keratinocytes which were induced to be- 
come quiescent (using a basal medium devoid of supple- 
mental mitogens) expressed a greater number of IFN-y 
receptors compared to rapidly growing, undifferenti- 
ated keratinocytes. When quiescent cells were re-acti- 
vated by adding the mitogens EGF or TGF-a, a time 
dependent decrease in the number of IFN-y receptors 
was observed after 24-48 hr. This reduction was mito- 
gen specific as IGF-1 (somatomedin-C) addition did not 
produce this reduction after 48 h r  exposure. The ability 
of both EGF and TGF-a to have similar effects on kera- 
tinocytes is not surprising since they share substantial 
amino acid sequence homology and bind to the same 
EGF surface receptor (Marquardt e t  al., 1984). 
The alterations in the number of keratinocyte high 
affinity IFN-y receptors had immunobiological signifi- 
cances, because the relative degree of induction of 
ICAM-1 and HLA-DR by IFN-y following treatments 
which either increased or decreased receptor numbers 
revealed parallel changes. For example, keratinocytes 
made quiescent by being placed in KBM, which had a 
greater number of IFN-y receptors as detected by 
ligand binding, also had an increased amount of ICAM- 
1IHLA-DR induced by IFN-y, compared to rapidly 
growing cells maintained in KGM. Conversely, when 
EGF or TGF-a was added to the KBM to become re- 
activated with diminished IFN-y ligand binding, there 
was decreased ICAM-1/HLA-DR induction by IFN-y. 
These in vitro immunobiological alterations are similar 
to those previously reported for human thyroid epithe- 
lial cells (Todd et  al., 1990) in which EGF or TGF-a 
(2-50 ngiml) inhibited the ability of IFN-y (1-2.5 Ulml) 
to induce HLA-DR expression. The ability of mitogens 
such as EGF to increase IFN-y production by T lympho- 
cytes (Abdullah et al., 19891, and a t  the same time 
reduce keratinocyte IFN-y receptors, may be part of an 
important reciprocal regulatory system operative be- 
tween immunocytes and epithelial cells. 
The modulation of keratinocyte growth in vitro in- 
cludes pro-proliferation induced by TGF-a or EGF, and 
anti-proliferation by IFN-y (Nickoloff et al., 1988). Pre- 
viously, we established that IFN-y down modulated 
high affinity keratinocyte EGF receptors (Nickoloff 
and Mitra, 1989), and this current work demonstrates 
that EGF/TGF-a can down modulate high affinity 
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IFN-y receptors. Taken together, these results suggest 
that there are highly reciprocal interactions between 
these grown modulatory systems operative in kerati- 
nocytes (Nickoloff, 1991a). These molecular interac- 
tions involving TGF-a/EGF receptors and IFN-y/IFN-y 
receptors on cultured keratinocytes may help explain 
several features of the psoriatic epidermis. IFN-y is 
detectable in psoriatic epidermis (Barker e t  al., 19911, 
yet there is significant keratinocyte hyperplasia, and 
only focal HLA-DR and ICAM-1 expression (reviewed 
in Nickoloff, 1991a). This is surprising because kerati- 
nocytes in vitro are extraordinarily sensitive to IF"-?, 
being substantially growth inhibited (Nickoloff et al., 
19841, and induced to strongly and diffusely express 
HLA-DR/ICAM-1 (Griffiths et al., 1989a,b). It has also 
been demonstrated that psoriatic epidermis contains 
markedly elevated TGF-a (Turbitt et al., 1990; Nick- 
oloff et al., 1991). Based on the current results, we can 
postulate this increased TGF-a may be responsible for 
down-modulating keratinocyte IFN-y receptors, thus 
rendering the hyperkinetic cells less responsive to the 
antiproliferative and immunomodulatory effects of 
IFN-y (Nickoloff et al., 1989; Baker e t  al., 1988). Future 
work aimed specifically at determining whether there 
are decreased numbers of high affinity cell surface 
IFN-y receptors on keratinocytes within lesions of pso- 
riasis seems indicated (Nickoloff, 1991a). Clearly, 
much additional work remains to be performed to more 
fully understand the complex, reciprocal, concentration 
dependent, and time dependent molecular interactions 
involving the aforementioned ligandireceptor combina- 
tions in cultured normal keratinocytes, and in diseases 
such as psoriasis. 
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